PATENT CLAIM ANALYSIS

Application Number: 15992126
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-12
Patent Classification: ["424", "725000"]

Abstract:
A method for treating a subject suffering from a developmental retinal vascular disorder by administering to the subject a composition which has a therapeutically effective amount of a dendrobium nobile lindley (DNL).

Claim (Index 6):
The method of  claim 1 , wherein the DNL treats a retinal ischemic damage caused by the developmental retinal vascular disorder induced by downregulating of norrie disease protein.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15490863', '14953026', '13499481', '13246057', '12645991']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7460214198085412
- 35 USC 102 Novelty (BERT): 0.534019729014878
- Combined Prediction Score: 0.7248212507291749
- Mean Citation Score: 260.90640599999995
- Max Citation Score: 363.78384
- Similarity Product: 269.78514471508026

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test